Similarly, Keratinocyte growth factor (KGF) aiming to restore the alveolar epithelial damages in the lung injury was studied in a Phase2 clinical trial for Acute Respiratory Distress Syndrome (ARDS) patients, thereby failing to improve their clinical outcomes. The gene discussed is FGF7; the disease is acute respiratory distress syndrome.